Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of Cefiderocol in Multidrug-Resistant Gram-Negative Central Nervous System Infections: Real Life Experience and State-of-the-Art.
Sollima A, Rossini F, Lanza P, Pallotto C, Meschiari M, Gentile I, Stellini R, Lenzi A, Mulé A, Castagna F, Lorenzotti S, Amadasi S, Van Hauwermeiren E, Saccani B, Fumarola B, Signorini L, Castelli F, Matteelli A. Sollima A, et al. Among authors: meschiari m. Antibiotics (Basel). 2024 May 16;13(5):453. doi: 10.3390/antibiotics13050453. Antibiotics (Basel). 2024. PMID: 38786181 Free PMC article.
Clinical Experience with Ceftazidime-Avibactam for the Treatment of Infections due to Multidrug-Resistant Gram-Negative Bacteria Other than Carbapenem-Resistant Enterobacterales.
Vena A, Giacobbe DR, Castaldo N, Cattelan A, Mussini C, Luzzati R, Rosa FG, Del Puente F, Mastroianni CM, Cascio A, Carbonara S, Capone A, Boni S, Sepulcri C, Meschiari M, Raumer F, Oliva A, Corcione S, Bassetti M. Vena A, et al. Among authors: meschiari m. Antibiotics (Basel). 2020 Feb 9;9(2):71. doi: 10.3390/antibiotics9020071. Antibiotics (Basel). 2020. PMID: 32050434 Free PMC article.
A Retrospective Whole-Genome Sequencing Analysis of Carbapenem and Colistin-Resistant Klebsiella Pneumoniae Nosocomial Strains Isolated during an MDR Surveillance Program.
Gentile B, Grottola A, Orlando G, Fregni Serpini G, Venturelli C, Meschiari M, Anselmo A, Fillo S, Fortunato A, Lista F, Pecorari M, Mussini C. Gentile B, et al. Among authors: meschiari m. Antibiotics (Basel). 2020 May 12;9(5):246. doi: 10.3390/antibiotics9050246. Antibiotics (Basel). 2020. PMID: 32408565 Free PMC article.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2020 Oct 21;18(1):405. doi: 10.1186/s12967-020-02573-9. J Transl Med. 2020. PMID: 33087150 Free PMC article. Clinical Trial.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C; TOCIVID-19 investigators, Italy. Perrone F, et al. J Transl Med. 2021 Oct 21;19(1):442. doi: 10.1186/s12967-021-03094-9. J Transl Med. 2021. PMID: 34674735 Free PMC article. No abstract available.
Combined Resistance to Ceftolozane-Tazobactam and Ceftazidime-Avibactam in Extensively Drug-Resistant (XDR) and Multidrug-Resistant (MDR) Pseudomonas aeruginosa: Resistance Predictors and Impact on Clinical Outcomes Besides Implications for Antimicrobial Stewardship Programs.
Meschiari M, Orlando G, Kaleci S, Bianco V, Sarti M, Venturelli C, Mussini C. Meschiari M, et al. Antibiotics (Basel). 2021 Oct 8;10(10):1224. doi: 10.3390/antibiotics10101224. Antibiotics (Basel). 2021. PMID: 34680805 Free PMC article.
Real-life experience with compassionate use of cefiderocol for difficult-to-treat resistant Pseudomonas aeruginosa (DTR-P) infections.
Meschiari M, Volpi S, Faltoni M, Dolci G, Orlando G, Franceschini E, Menozzi M, Sarti M, Del Fabro G, Fumarola B, Guarneri F, Lanza P, Lorenzotti S, Saccani B, Signorini L, Van Hauwermeiren E, Gatti M, Pea F, Castelli F, Mussini C. Meschiari M, et al. JAC Antimicrob Resist. 2021 Dec 11;3(4):dlab188. doi: 10.1093/jacamr/dlab188. eCollection 2021 Dec. JAC Antimicrob Resist. 2021. PMID: 34909691 Free PMC article.
Long-Term Impact of the COVID-19 Pandemic on In-Hospital Antibiotic Consumption and Antibiotic Resistance: A Time Series Analysis (2015-2021).
Meschiari M, Onorato L, Bacca E, Orlando G, Menozzi M, Franceschini E, Bedini A, Cervo A, Santoro A, Sarti M, Venturelli C, Biagioni E, Coloretti I, Busani S, Girardis M, Lòpez-Lozano JM, Mussini C. Meschiari M, et al. Antibiotics (Basel). 2022 Jun 20;11(6):826. doi: 10.3390/antibiotics11060826. Antibiotics (Basel). 2022. PMID: 35740232 Free PMC article.
123 results